X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1716) 1716
Publication (180) 180
Book Review (68) 68
Book Chapter (15) 15
Dissertation (5) 5
Book / eBook (3) 3
Conference Proceeding (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1298) 1298
index medicus (1088) 1088
oncology (719) 719
phase-ii (670) 670
phase-ii trial (462) 462
female (439) 439
cancer (426) 426
male (410) 410
chemotherapy (396) 396
care and treatment (324) 324
middle aged (309) 309
pharmacology & pharmacy (309) 309
treatment outcome (309) 309
animals (277) 277
aged (274) 274
research (269) 269
adult (261) 261
clinical trials (253) 253
antineoplastic agents - therapeutic use (229) 229
clinical trials, phase ii as topic (221) 221
health aspects (202) 202
metastasis (182) 182
prognosis (174) 174
radiotherapy (172) 172
tumors (171) 171
antineoplastic combined chemotherapy protocols - therapeutic use (170) 170
therapy (165) 165
medicine, research & experimental (152) 152
double-blind (150) 150
drug therapy (150) 150
cancer therapies (146) 146
review (146) 146
survival (132) 132
surgery (131) 131
patients (129) 129
neoplasm staging (128) 128
clinical trials as topic (123) 123
medicine (122) 122
clinical trials, phase iii as topic (117) 117
radiation-therapy (116) 116
carcinoma (115) 115
combined modality therapy (114) 114
studies (112) 112
development and progression (101) 101
usage (101) 101
cisplatin (100) 100
medical research (100) 100
disease-free survival (98) 98
analysis (96) 96
neoplasms. tumors. oncology. including cancer and carcinogens (96) 96
trial (93) 93
aged, 80 and over (92) 92
efficacy (92) 92
open-label (92) 92
research article (91) 91
statistics & probability (91) 91
randomized controlled trials as topic (89) 89
antineoplastic agents - pharmacology (88) 88
diagnosis (87) 87
retrospective studies (86) 86
safety (86) 86
mutation (85) 85
patient outcomes (85) 85
toxicity (85) 85
radiation therapy (83) 83
risk factors (83) 83
article (82) 82
biotechnology & applied microbiology (82) 82
clinical trials, phase ii as topic - methods (82) 82
dose-response relationship, drug (81) 81
immunotherapy (80) 80
survival analysis (80) 80
breast cancer (79) 79
genetic aspects (79) 79
survival rate (78) 78
antibodies, monoclonal - therapeutic use (77) 77
hematology (77) 77
mice (76) 76
medical prognosis (75) 75
research design (75) 75
cell line, tumor (72) 72
kinases (72) 72
endothelial growth-factor (71) 71
methods (71) 71
clinical-trials (70) 70
prostate cancer (70) 70
cell lung-cancer (69) 69
lung cancer (69) 69
apoptosis (67) 67
expression (66) 66
randomized phase-ii (66) 66
randomized-trial (66) 66
biochemistry & molecular biology (64) 64
disease progression (64) 64
neoplasm metastasis (64) 64
dosage and administration (63) 63
bevacizumab (61) 61
follow-up studies (61) 61
in-vitro (61) 61
adolescent (60) 60
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1718) 1718
French (12) 12
Japanese (3) 3
Polish (3) 3
Portuguese (3) 3
Chinese (1) 1
German (1) 1
Hungarian (1) 1
Italian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Icarus, ISSN 0019-1035, 07/2009, Volume 202, Issue 1, pp. 160 - 180
The availability of asteroid spectral measurements extending to the near-infrared, resulting from the development of new telescopic instruments (such as SpeX... 
Spectroscopy | Asteroids | POPULATION | MAIN-BELT | PHASE-II | TELESCOPE FACILITY | SPECTRAL PROPERTIES | DISCOVERY | EARTH OBJECTS | ASTRONOMY & ASTROPHYSICS | TARGETS | IRTF | SPECTROSCOPIC SURVEY
Journal Article
Journal Article
Journal of Rheumatology, ISSN 0315-162X, 2014, Volume 41, Issue 5, pp. 837 - 852
Journal Article
Journal of Rheumatology, ISSN 0315-162X, 01/2018, Volume 45, Issue 1, pp. 14 - 21
Objective. To assess the safety and efficacy of baricitinib in patients with rheumatoid arthritis (RA) up to 128 weeks in a phase IIb study (NCT01185353).... 
Clinical efficacy safety | Phase II | Longterm | Rheumatoid arthritis | Baricitinib | THERAPY | BARICITINIB | SAFETY | LONGTERM | HERPES-ZOSTER | RHEUMATOID ARTHRITIS | CLINICAL EFFICACY | RHEUMATOLOGY | PHASE II
Journal Article
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, ISSN 0926-9959, 09/2018, Volume 32, Issue 9, pp. 1507 - 1514
BackgroundSecukinumab, a fully human monoclonal antibody that selectively neutralizes IL-17A, has been shown to have significant efficacy and a favourable... 
ADALIMUMAB | USTEKINUMAB | SEVERE PLAQUE PSORIASIS | DOUBLE-BLIND | PHASE-II | REGIMEN | EXPERIENCE | AGENTS | LONG-TERM EFFICACY | REGISTRY | DERMATOLOGY
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 75, Issue 5, pp. 897 - 905
Background Psoriasis is a systemic inflammatory condition that is associated with a higher risk of cardiovascular (CV) disease. Tofacitinib is being... 
Dermatology | major adverse cardiovascular events psoriasis | cardiovascular outcomes | cardiovascular risk factors | tofacitinib | RHEUMATOID-ARTHRITIS | MORTALITY | METABOLIC SYNDROME | MYOCARDIAL-INFARCTION | VASCULAR-DISEASES | DERMATOLOGY | LDL CHOLESTEROL | HEART-DISEASE | JANUS KINASE INHIBITOR | HDL CHOLESTEROL | ASSOCIATION | Blood Pressure | Glycated Hemoglobin A - analysis | Cholesterol - blood | Humans | Middle Aged | Male | Protein Kinase Inhibitors - adverse effects | Metabolic Syndrome - blood | Clinical Trials, Phase III as Topic | Dyslipidemias - blood | Cardiovascular Diseases - epidemiology | Pyrroles - adverse effects | Adult | Female | C-Reactive Protein - analysis | Psoriasis - blood | Pyrroles - therapeutic use | Metabolic Syndrome - epidemiology | Psoriasis - drug therapy | Comorbidity | Risk Factors | Treatment Outcome | Psoriasis - epidemiology | Dyslipidemias - epidemiology | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Piperidines - adverse effects | Pyrimidines - adverse effects | Triglycerides - blood | Clinical Trials, Phase II as Topic | Health maintenance organizations | Psoriasis | Patient outcomes | Cardiovascular diseases | Cardiology | Pharmaceutical industry | Epidemiology | Risk factors | Rheumatoid factor | Medical research | Low density lipoproteins | Medicine, Experimental | Heart attack
Journal Article
Journal Article
Journal Article
Geoscientific Model Development, ISSN 1991-959X, 10/2018, Volume 11, Issue 10, pp. 3945 - 3982
We document model updates and present and discuss modeling and validation results from a further developed production-tagged aerosol module, OsloAero5.3, for... 
BLACK CARBON | GEOSCIENCES, MULTIDISCIPLINARY | COMMUNITY ATMOSPHERE MODEL | AIRCRAFT OBSERVATIONS | BIOGENIC EMISSIONS | CLOUD MICROPHYSICS | AEROCOM PHASE-II | HETEROGENEOUS ICE NUCLEATION | PARTICLE FORMATION | CARBON VERTICAL PROFILES | CLIMATE MODEL | Models | Comparative analysis | Sulfates | Optical properties | Dimethyl sulfide | Aerosols | Environmental aspects | Emissions (Pollution) | Analysis | Sky | Organic carbon | Nucleation | Clouds | Atmospheric models | Mass ratios | Remote observing | Cloud-climate relationships | Ratios | Condensates | Aerosol production | Radiative forcing | Dust clouds | Condensation nuclei | Oceans | Pollution sources | Biomass burning | Climate models | Aerosol absorption | Atmospheric particulates | Emissions | Mass | Organic chemistry | Satellites | Intergovernmental Panel on Climate Change | Incineration | Computer applications | Optical analysis | Black carbon | Tracers | Organic matter | Bias | Cloud condensation nuclei | Remote sensing | Aerosols-cloud relationships | Earth | Life cycle | Absorption | Secondary aerosols | Life cycle engineering | Modelling | Carbon | Aerosol chemistry | Anthropogenic factors | Sulphides | Burning | Dust | Ice nucleation | Interactions | Sulfate | Computing time | Life cycles | Geology | Naturvetenskap | Natural Sciences | Earth and Related Environmental Sciences | Geovetenskap och miljövetenskap
Journal Article